发明名称 Adenosine receptor modulators
摘要 Described is the use of compounds of formula II, III, or IV for the manufacture of medicaments for the control or treatment of Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation, and for use as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardiaprotective agents; for which the substituents are defined herein.
申请公布号 NZ520241(A) 申请公布日期 2004.05.28
申请号 NZ20010520241 申请日期 2001.02.15
申请人 F 发明人 BORRONI, EDILIO MAURIZIO;HUBER-TROTTMANN, GERDA;KILPATRICK, GAVIN JOHN;NORCROSS, ROGER DAVID
分类号 A61K31/00;A61K31/44;A61K31/4418;A61K31/443;A61K31/4436;A61K31/444;A61K31/4709;A61K31/505;A61K31/506;A61K31/513;A61K31/519;A61K31/5377;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P21/02;A61P25/04;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P37/08;A61P43/00;C07D213/57;C07D213/85;C07D239/42;C07D239/46;C07D239/47;C07D239/48;C07D239/56;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D405/04;C07D405/14;C07D407/04;C07D407/14;C07D409/04;C07D409/14;C07D413/04;C07D495/04;C07D521/00;(IPC1-7):A61K31/00;A61K31/435;C07D213/02;C07C211/03;C07C255/50;A61P29/00 主分类号 A61K31/00
代理机构 代理人
主权项
地址